Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Category

Sub-category

Conference

The hidden biology of addiction and cancer

Prof Raphael Cuomo - UC San Diego School of Medicine, San Diego, USA

The hidden biology of addiction and cancer ( Prof Raphael Cuomo - UC San Diego School of Medicine, San Diego, USA )

Independent clones in CLL show oligoclonality and early evolution patterns

Dr Ferran Nadeu - August Pi i Sunyer Biomedical Research Institute, Barcelona...

Independent clones in CLL show oligoclonality and early evolution patterns ( Dr Ferran Nadeu - August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain )

Ordronextamab shows durable efficacy in R/R follicular lymphoma: 2-Year ELM-2...

Prof Stefano Luminari - University of Modena and Reggio Emilia, Modena, Italy

Ordronextamab shows durable efficacy in R/R follicular lymphoma: 2-Year ELM-2 phase 2 results ( Prof Stefano Luminari - University of Modena and Reggio Emilia, Modena, Italy )

Bexmarilimab plus azacitidine shows promising response in relapsed/refractory...

Dr Anthony Stein - City of Hope, Duarte, USA

$Bexmarilimab plus azacitidine shows promising response in relapsed/refractory myelodysplasia ( Dr Anthony Stein - City of Hope, Duarte, USA )$

Subcutaneous isatuximab via on-body delivery system matches IV efficacy with...

Prof Xavier Leleu - Poitiers University Hospital, Poitiers, France

Subcutaneous isatuximab via on-body delivery system matches IV efficacy with better experience in RRMM ( Prof Xavier Leleu - Poitiers University Hospital, Poitiers, France )

Triple combination of venetoclax-ibrutinib-obinutuzumab prolongs PFS compared...

Dr Moritz Fürstenau - University of Cologne, Cologne, Germany

Triple combination of venetoclax-ibrutinib-obinutuzumab prolongs PFS compared to venetoclax-CD20-antibodies ( Dr Moritz Fürstenau - University of Cologne, Cologne, Germany )

The combination of acimtamig and AlloNK therapy demonstrates promising efficacy...

Dr Amitkumar Mehta - University of Alabama at Birmingham, Birmingham, USA

The combination of acimtamig and AlloNK therapy demonstrates promising efficacy in R/R cHL ( Dr Amitkumar Mehta - University of Alabama at Birmingham, Birmingham, USA )

POLA-R-GEMOX regimen is a promising option for relapsed/refractory diffuse...

Dr Matthew Matasar - Rutgers Cancer Institute, New Brunswick, USA

$POLA-R-GEMOX regimen is a promising option for relapsed/refractory diffuse large B-cell lymphoma ( Dr Matthew Matasar - Rutgers Cancer Institute, New Brunswick, USA )$

Ropeginterferon Alfa-2b shows superior efficacy over anagrelide in essential...

Dr Ruben A. Mesa - Atrium Health Wake Forest Baptist Comprehensive Cancer...

Ropeginterferon Alfa-2b shows superior efficacy over anagrelide in essential thrombocythaemia ( Dr Ruben A. Mesa - Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, USA )

Rusfertide shows promise for polycythemia vera treatment

Dr Andrew Kuykendall - Moffitt Cancer Center, Tampa, USA

Rusfertide shows promise for polycythemia vera treatment ( Dr Andrew Kuykendall - Moffitt Cancer Center, Tampa, USA )

Understanding AL amyloidosis: Treatment and diagnosis

Dr Jay Datukan, St. Luke's Medical Center, Quezon City, Filipinas

Understanding AL amyloidosis: Treatment and diagnosis ( Dr Jay Datukan, St. Luke's Medical Center, Quezon City, Filipinas )

Bloodstream buzz: Amplifying haematology through social media

Dr Anne Kristine Quero - Philippine General Hospital Philippine General...

Bloodstream buzz: Amplifying haematology through social media ( Dr Anne Kristine Quero - Philippine General Hospital Philippine General Hospital, Manila, Philippines )

More from ecancer